CQP(SZ:000950) Zheng Quan Zhi Xing·2025-07-28 16:26Core Viewpoint - The legal opinion letter confirms the legality and validity of the procedures, qualifications, and voting results of the 2025 third extraordinary general meeting of shareholders of Chongqing Pharmaceutical Holdings Co., Ltd. [2][8] Group 1: Meeting Procedures - The meeting was convened by the board of directors and held on July 28, 2025, at the company's conference room in Chongqing, with proper notification of time, location, and agenda [3][4] - The voting was conducted through both on-site and online platforms, with specific time slots for each [3][4] Group 2: Attendance and Qualifications - A total of 247 shareholders and their proxies attended the meeting, representing 1,025,248,471 shares, which is 59.3252% of the total voting shares [4][5] - The qualifications of the attendees and the convenor were verified to be in compliance with relevant laws and regulations [4][8] Group 3: Agenda and Voting Results - The meeting reviewed and voted on the agenda items as previously announced, with no additional temporary motions presented [5][8] - The voting results showed that 1,014,780,662 shares (98.9790%) were in favor, 10,263,109 shares (1.0010%) were against, and 204,700 shares (0.0200%) were abstained [5][6][7]